Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3/5
Mesoblast Ltd (MSB AU)
Watchlist
Contact IR
57
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
Contact IR
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
26 Mar 2025 23:12
Ryoncil Is Now Available For Purchase In The United States
Attachment
Exchange Announcement •
13 Mar 2025 22:57
Ryoncil Published in All Four Major Drug Pricing Compendia
Attachment
Exchange Announcement •
12 Mar 2025 22:54
CEO Presentation at ISCT North America
Attachment
Exchange Announcement •
12 Mar 2025 22:50
Appendix 3Y for Gregory George
Attachment
Exchange Announcement •
12 Mar 2025 07:24
CEO to Deliver Featured Presentation at ISCT North America
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2
x